Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SeaStar Medical Holding (ICUCW) Shares Outstanding (Diluted Average) (2023 - 2025)

SeaStar Medical Holding's Shares Outstanding (Diluted Average) history spans 3 years, with the latest figure at $10.0 million for Q2 2025.

  • For Q2 2025, Shares Outstanding (Diluted Average) rose 235.48% year-over-year to $10.0 million; the TTM value through Jun 2025 reached $10.0 million, up 235.48%, while the annual FY2024 figure was $3.7 million, 331.88% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $10.0 million in Q2 2025 per ICUCW's latest filing, up from $8.6 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $13.0 million in Q1 2023 to a low of $559385.0 in Q2 2023.
  • Average Shares Outstanding (Diluted Average) over 3 years is $4.7 million, with a median of $3.2 million recorded in 2024.
  • The largest YoY upside for Shares Outstanding (Diluted Average) was 431.88% in 2024 against a maximum downside of 79.39% in 2024.
  • A 3-year view of Shares Outstanding (Diluted Average) shows it stood at $866813.0 in 2023, then soared by 331.88% to $3.7 million in 2024, then skyrocketed by 166.62% to $10.0 million in 2025.
  • Per Business Quant, the three most recent readings for ICUCW's Shares Outstanding (Diluted Average) are $10.0 million (Q2 2025), $8.6 million (Q1 2025), and $3.7 million (Q4 2024).